| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT06836973 | Blinatumomab for Treatment of Refractory Myasthenia Gravis | Myasthenia Gravis | Not Yet Recruiting |
| Not specified | |||
| NCT07079020 | Efgartigimod for Consolidation Therapy in gMG | Myasthenia Gravis | Not Yet Recruiting |